Intuitive Surgical, Inc. (ISRG) Operating Margin
- Operating margin · 12 months: Value 31.28%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 31.28% | Operating income / revenue. Period ending 2026-06-30. $3.45B ÷ $11.03B × 100 ≈ 31.28% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 3.45B USD | Operating Income (Loss) |
| Revenue | 11.03B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 3.68B USD | Cost of Goods and Services Sold |
| Research and development | 1.41B USD | Research and Development Expense |
| Selling, general and administration | 2.49B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.45B | $11.03B | $3.68B | $1.41B | $2.49B | 31.28% |
| 2026-03-31 | $3.22B | $10.58B | $3.57B | $1.36B | $2.43B | 30.45% |
| 2025-12-31 | $2.95B | $10.06B | $3.42B | $1.31B | $2.38B | 29.27% |
| 2025-09-30 | $2.82B | $9.61B | $3.23B | $1.25B | $2.31B | 29.30% |
| 2025-06-30 | $2.63B | $9.14B | $3.05B | $1.21B | $2.25B | 28.80% |
| 2025-03-31 | $2.46B | $8.71B | $2.87B | $1.18B | $2.21B | 28.20% |
| 2024-12-31 | $2.35B | $8.35B | $2.72B | $1.15B | $2.14B | 28.12% |
| 2024-09-30 | $2.06B | $7.87B | $2.60B | $1.11B | $2.09B | 26.24% |
| 2024-06-30 | $1.95B | $7.57B | $2.51B | $1.07B | $2.04B | 25.79% |
| 2024-03-31 | $1.85B | $7.32B | $2.46B | $1.04B | $1.97B | 25.26% |
| 2023-12-31 | $1.77B | $7.12B | $2.39B | $998.80M | $1.96B | 24.80% |
| 2023-09-30 | $1.69B | $6.85B | $2.29B | $982.80M | $1.89B | 24.66% |
| 2023-06-30 | $1.62B | $6.66B | $2.22B | $950.50M | $1.88B | 24.34% |
| 2023-03-31 | $1.56B | $6.43B | $2.13B | $913.40M | $1.83B | 24.21% |
| 2022-12-31 | $1.58B | $6.22B | $2.03B | $879.00M | $1.74B | 25.35% |
| 2022-09-30 | $1.66B | $6.12B | $1.97B | $818.30M | $1.67B | 27.05% |
| 2022-06-30 | $1.70B | $5.96B | $1.90B | $766.70M | $1.60B | 28.48% |
| 2022-03-31 | $1.81B | $5.91B | $1.84B | $721.70M | $1.53B | 30.69% |
| 2021-12-31 | $1.82B | $5.71B | $1.75B | $671.00M | $1.47B | 31.89% |
| 2021-09-30 | $1.79B | $5.49B | $1.70B | $637.40M | $1.37B | 32.55% |
| 2021-06-30 | $1.61B | $5.16B | $1.62B | $626.90M | $1.31B | 31.27% |
| 2021-03-31 | $1.18B | $4.55B | $1.53B | $607.80M | $1.23B | 26.01% |
| 2020-12-31 | $1.05B | $4.36B | $1.50B | $595.10M | $1.22B | 24.09% |
| 2020-09-30 | $1.03B | $4.31B | $1.45B | $601.90M | $1.23B | 23.95% |
| 2020-06-30 | $1.13B | $4.36B | $1.43B | $582.80M | $1.21B | 25.86% |
| 2020-03-31 | $1.41B | $4.60B | $1.43B | $560.40M | $1.21B | 30.52% |
| 2019-12-31 | $1.37B | $4.48B | $1.37B | $557.30M | $1.18B | 30.69% |
| 2019-09-30 | $1.31B | $4.25B | $1.30B | $520.60M | $1.12B | 30.82% |
| 2019-06-30 | $1.26B | $4.04B | $1.23B | $492.30M | $1.06B | 31.10% |
| 2019-03-31 | $1.17B | $3.85B | $1.17B | $466.60M | $1.04B | 30.51% |
| 2018-12-31 | $1.20B | $3.72B | $1.12B | $418.10M | $986.60M | 32.21% |
| 2018-09-30 | $1.19B | $3.56B | (m) | $385.30M | $921.10M | 33.37% |
| 2018-06-30 | $1.16B | $3.45B | (m) | $361.10M | $903.80M | 33.52% |
| 2018-03-31 | $1.14B | $3.30B | (m) | $350.60M | $829.60M | 34.52% |
| 2017-12-31 | $1.05B | $3.13B | (m) | $328.60M | $810.90M | 33.71% |
| 2017-09-30 | $992.00M | $2.99B | (m) | $310.60M | $785.40M | 33.14% |
| 2017-06-30 | $969.80M | $2.87B | (m) | $289.80M | $748.60M | 33.79% |
| 2017-03-31 | $957.70M | $2.78B | (m) | $259.90M | $733.60M | 34.40% |
| 2016-12-31 | $945.20M | $2.70B | (m) | $239.60M | $705.30M | 34.95% |
| 2016-09-30 | $926.70M | $2.62B | (m) | $223.10M | $671.90M | 35.32% |
| 2016-06-30 | $860.20M | $2.53B | (m) | $211.50M | $658.80M | 33.99% |
| 2016-03-31 | $788.60M | $2.45B | (m) | $206.20M | $651.30M | 32.23% |
| 2015-12-31 | $740.00M | $2.38B | (m) | $197.40M | $640.50M | 31.04% |
| 2015-09-30 | $680.20M | $2.31B | (m) | $192.10M | $640.20M | 29.41% |
| 2015-06-30 | $649.40M | $2.27B | (m) | $188.60M | $639.30M | 28.57% |
| 2015-03-31 | $618.60M | $2.20B | (m) | $179.40M | $637.20M | 28.13% |
| 2014-12-31 | $544.80M | $2.13B | (m) | $178.00M | $691.00M | 25.56% |
| 2014-09-30 | $567.30M | $2.10B | (m) | $172.40M | $678.70M | 26.97% |
| 2014-06-30 | $582.40M | $2.05B | (m) | $168.10M | $664.00M | 28.38% |
| 2014-03-31 | $657.90M | $2.12B | (m) | $169.10M | $648.30M | 31.06% |
| 2013-12-31 | $852.50M | $2.27B | (m) | $167.70M | $574.00M | 37.64% |
| 2013-09-30 | $892.00M | $2.30B | (m) | $167.70M | $574.40M | 38.81% |
| 2013-06-30 | $929.20M | $2.34B | (m) | $174.20M | $564.10M | 39.76% |
| 2013-03-31 | $936.00M | $2.29B | (m) | $173.20M | $539.50M | 40.78% |
| 2012-12-31 | $878.10M | $2.18B | (m) | $170.00M | $522.20M | 40.30% |
| 2012-09-30 | $829.50M | $2.07B | (m) | $169.70M | $496.10M | 40.14% |
| 2012-06-30 | $797.00M | $1.98B | (m) | $155.40M | $478.30M | 40.35% |
| 2012-03-31 | $739.80M | $1.86B | (m) | $147.20M | $463.90M | 39.68% |
| 2011-12-31 | $694.80M | $1.76B | (m) | $140.20M | $438.80M | 39.54% |
| 2011-09-30 | $649.00M | $1.65B | (m) | $131.40M | $412.60M | 39.34% |
| 2011-06-30 | $602.20M | $1.55B | (m) | $122.90M | $393.00M | 38.91% |
| 2011-03-31 | $573.80M | $1.47B | (m) | $119.40M | $375.10M | 38.97% |
| 2010-12-31 | $555.20M | $1.41B | (m) | $116.00M | $358.80M | 39.29% |
| 2010-09-30 | $529.94M | $1.35B | (m) | $109.20M | $341.91M | 39.35% |
| 2010-06-30 | $502.34M | $1.28B | (m) | $106.90M | $320.21M | 39.17% |
| 2010-03-31 | $462.14M | $1.19B | (m) | $101.80M | $298.91M | 38.76% |
| 2009-12-31 | $377.44M | $1.05B | (m) | $95.10M | $278.51M | 35.87% |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $310.83M | $874.92M | (m) | $79.37M | $230.57M | 35.53% |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $206.74M | $600.83M | (m) | $48.86M | $158.69M | 34.41% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |